hepatocirrhosis

hepatocirrhosis

1. The clinical analysis of cholecyst cliff ultrasonography in 178 patients with hepatocirrhosis

178例肝硬化患者胆囊壁声像图临床分析

2. Orem selfmanage model used in the hepatocirrhosis has better effect, the model is await to be spread and using.

Orem自理模式用于肝硬化病人的护理有较好的效果,该护理模式有待进一步推广和应用。

3. Research of brain function of hepatocirrhosis patients by P300 and power spectral density of EEG.Journal of Brain and Nervous Disease,2003;

P300及脑电功率谱用于肝硬化病人脑功能的研究.脑与神经疾病杂志,2003;

4. [Abstract] Objective To measure and effect of family nursing intervention to the patients with hepatocirrhosis.

[摘要] 目的 探讨肝硬化患者家庭护理干预的措施以及效果。

5. Diagnosis of portal hypertantion with 99 m Tc MIBI in hepatocirrhosis

~(99m)tc-MIBI 诊断肝硬化门静脉高压的临床研究

6. Experimental Study of Decoction for Removing Blood Stasis(Xiayuxue tang) on the Prevention and Treatment of Hepatocirrhosis

下瘀血汤防治肝硬化的实验研究

7. The Clinical Observation of Navel Spreading with Traditional Chinese Medicine on Ascites Induced by Hepatocirrhosis with Hepatitis

中药敷脐治疗肝炎肝硬化腹水的临床观察

8. Effect observation of navel administration with Chinese traditional medicine on refractory ascites induced by hepatocirrhosis and nursing measures

中药敷脐治疗肝硬化难治性腹水的效果观察与护理

9. Clinical Observation on the Treatment of 45 Cases of Hepatocirrhosis Hydroperitoneum Caused by Late Bilharziasis With Combination of Traditional Chinese and Western Medicine

中西医结合治疗晚期血吸虫病肝硬化腹水45例临床观察

10. Evaluation of the combination treatment of traditional Chinese medicine and western medicine on spontaneous bacterial peritonitis associated with hepatocirrhosis

中西医结合治疗肝硬化并自发性细菌性腹膜炎疗效探讨

11. Clinical Observation on Ascites due to Hepatocirrhosis Treated with Integrated TCM and WM

中西医结合治疗肝硬化腹水临床观察

12. Keywords hepatitis B patients;hepatocirrhosis;quality of life;assessment;

乙型病毒性肝炎;肝硬化;生存质量;评价;

13. The infection of HBV may cause acute and chronic hepatitis B,and potentially lead to hepatocirrhosis and liver cancer.

乙型肝炎病毒(HBV)感染可引起急性和慢性乙型肝炎,最终可能导致肝硬化、肝癌等严重后果。

14. Keywords Hepatitis B virus DNA;Hepatocirrhosis after hepatitis B;Hepatitis B markers;

乙型肝炎病毒DNA;乙型肝炎后肝硬化;乙型肝炎标志物;

15. Village doctor, 59. Died of hepatocirrhosis caused by Schistosomiasis.

乡村医生，59岁，死于由血吸虫病引发的肝硬化。

16. forepart of hepatocirrhosis

代偿性肝硬化

17. Keywords B ultrasound Alcoholic hepatocirrhosis Early diagnosis Nang Nationality;

关键词B超;酒精性肝损害;早期诊断;藏族;

18. Keywords Octreotide;weasand tummy varix;hemorrhage;hepatocirrhosis;

关键词奥曲肽;食管胃静脉曲张;出血;肝硬化;

19. Keywords hepatocirrhosis;liver carcinoma;carbohydrate antigen 199（CA199）;alphafetoprotein（AFP）;

关键词肝硬化;肝癌;糖类抗原199;甲胎蛋白;

20. Keywords Hepatocirrhosis Liver blood flow Treatment;

关键词肝硬变;肝血流量;治疗;

21. Keywords Hilum spread clysis Hepatocirrhosis Ascites High nitrogen content blood;

关键词脐敷灌肠;肝硬化;腹水;氮质血症;

22. Key words hyaluronic acid（HA） cholyglycine（CG） laminin（LN） chronic hepatitis hepatocirrhosis

关键词透明质酸（HA）甘胆酸（CG）层粘连蛋白（LN）慢性肝炎肝硬化

23. It could prevent cancers and good for body immunity, also it has impact to hepatocirrhosis, diabetes, edema, etc.

具有防癌、抗癌及提高人体免疫功能的作用，对肝硬化、糖尿病、水肿、脚气病、小便不利等症有显著疗效。

24. Joined treatment of bypath and disconnection for hepatocirrhosis with portal hypertension bleeding

分流断流联合术治疗肝硬化门脉高压症出血

25. The root of red- rooted salvia compound prescribe injects the hepatocirrhosis 30 observations of the liquid treatment

复方丹参治疗肝硬化30例观察

26. The influence of Compound Hanfangji medical granulate on portal hemodynamics in patients with hepatocirrhosis

复方汉防己冲剂对肝硬化门静脉血流量的影响

27. The clinical study of hepatocirrhosis therapy by using of Fu Fang Bie Jia Ruan Gan Pian.

复方鳖甲软肝片治疗50例肝纤维化的临床研究

28. Lots of clinical practice proves that TCM has its own superiority to acute virus hepatitis, chronic virus hepatitis, hepatocirrhosis and so on.

大量的临床实践证明，中医药具有治疗确切，资料丰富，价格低廉，毒副作用小等优点，在治疗各类型病毒性急性肝炎、慢性肝炎、肝硬化等疾病具有自身优势。

29. Keywords Octriotid Hepatocirrhosis Varicosis Hemorrhage;

奥曲肽;肝硬变;静脉曲张;出血;

30. The method has been applied to the practical abdominal MRI, and showed higher accuracy in the diagnosis of hepatocirrhosis than single neural network.

将该方法应用于实际的腹部MRI图像，证明了其对肝硬化程度诊断的准确率显著高于单一神经网络的方法。

31. Effect of Frequent Small Hematometachysis on Blood Rheology in Patients with Hepatocirrhosis Accompanied by Hemorrhage of Upper Digestive Tract and Its Therapeutic Evaluation

少量多次输血对肝硬化并上消化道出血患者血液流变学的影响及临床疗效评价

32. A Pig Case of Hypertrophic Hepatocirrhosis Found in Slaughtering Inspection

屠宰检疫中猪肥大性肝硬变一例

33. Laparoscopic cholecystectomy in the patients with gallbladder disease combined with hepatocirrhosis[J].

引用该论文 左国华,梁平,李靖,丁生才,李洪艳.

34. Clinical observation of treating hepatocirrhosis diahrrhea with Micro-ecological production P.O.Bifidobiogcn

微生态制剂丽珠肠乐治疗肝硬化腹泻临床观察

35. The AST/ALT ratio in HBeAg positive and HBeAg negtive was no statistics significance in CHB group and Hepatocirrhosis group(P>0.05).

慢性乙型肝炎组与肝炎后肝硬化组各组内HBeAg阳性的AST/ALT比值与HBeAg阴性的AST/ALT比值比较,无统计学意义(P>0.05)。

36. The level of TF3,TF4 and TSH in chronic hepatitis,hepatocirrhosis compensated and hepatocirrhosis decompensated were analogous,lower than those in normal group(P<0.001,P<0.005,P<0.005).

慢性肝炎、肝硬化代偿期与失代偿期的TF3、TF4及促甲状腺激素(TSH)表现基本一致,分别较正常组有明显下降(P<0.001,P<0.005,P<0.005),且与肝脏损害程度成正比;

37. Chronic hepatitis especially chronic active hepatitis is apt to be hepatocirrhosis and carcinoma.

慢性肝炎，尤其是慢性活动性肝炎易向肝硬化、肝癌转化，严重影响人类健康。

38. Keywords Hand-assisted laparoscopy;Splenectomy;Azygos-portal disconnection;Hepatocirrhosis;

手助腹腔镜手术;脾切除;门奇静脉断流术;肝硬化;

39. Objective: To study the effect of ultraviolet blood irradiation and oxygenation (UBIO) on liver trauma after operation for symptom of hepatocirrhosis portal hypertension.

摘要目的：探讨光量子血氧疗法(UBIO)在肝硬化门脉高压症术后肝损伤治疗中的应用。

40. Methods:47 cases with Hepatocirrhosis were randomly divided into the treatment group(28 cases) and the contrast group(19 cases).

方法:选择肝炎后肝硬化患者47例,其中口服苦参素软胶囊治疗28例(治疗组),与常规方法治疗19例(对照组)比较。

41. Methods NI and clinical features of old patients with hepatocirrhosis in a hospital in recent 10 years were analysed retrospectively.

方法回顾性总结分析某院近10年来出院和病死的老年肝硬化患者的临床特点及医院感染的发生情况。

42. Methods To determine the indexes of erythrocyte、leukocyte and thrombocyte of hepatocirrhosis in patients.

方法测定肝硬化患者血液中红细胞、白细胞、血小板等指标。

43. Methods: 40 cases of hepatocirrhosis and 20 cases of chronic liver illness without function damage proved by clinic were observed and compaxed with the results of X-ray chest film and CT scan.

方法：分析经临床确诊肝硬化40例及慢性肝病无肝功能损害20例的胸部平片与CT扫描结果。

44. Early hepatocirrhosis

早期肝硬化

45. dampness, qi-deficiency, qi-stasis, heat and blood stasis are more common in early hepatocirrhosis;

早期肝硬化患者以湿、气虚、气郁、热、血瘀为多；

46. It is concluded that the cause of death in this case was botulism rather than hepatocirrhosis.

本病例死因应为细菌性食物中毒而非肝硬化。

47. Effects of preoperative ultraviolet blood irradiation oxygen therapy on cirrhotic patients with hepatocirrhosis portal hypertension

术前光量子血氧疗法对肝硬化门静脉高压症的影响

48. Lin He-he's Experience of Treatment over Hepatocirrhosis Ascites

林鹤和治肝硬化腹水经验

49. Keywords seed oil of hippophae rhamnoides L.（SOHR）;D GaIN;hepatocirrhosis;immunopotentiation;

沙棘籽油;D-半乳糖胺;肝损伤;免疫增强作用;

50. Effects and comparison of seed oil and sarcocarp oil of Hippophae rhamnoides on rats with experimental hepatocirrhosis

沙棘籽油和果油对小鼠实验性肝损伤的保护作用及对比研究

51. Besides, it can cure or prevent some diseases of heart and blood vessel and incretion system, even hepatocirrhosis etc.

由于它的特殊的免疫功能，在全世界各地被广泛应用于功能性食品、药品和保健品中。

52. Objective:To analyse the levels of serum C-reactive protein(CRP) and procalcitonin(PCT) in hepatocirrhosis patients with severe infection.

目的:分析肝硬化并发严重感染时血清前降钙素、C反应蛋白的变化及其临床意义。

53. Objective Purpose:In the study western medicine consociation treatment hepatocirrhosis ascites clinical curative effect.

目的:探讨中西药联合治疗肝硬化腹水的临床疗效。

54. Objective: To study the character of the psychological needs of hepatocirrhosis inpa-tients, and providing theoretical foundation for holistic nursing.

目的:探讨肝硬化住院病人心理需要特点,为整体护理的实施提供理论依据。

55. Objective: To find a accessiorial diagnose of hepatocirrhosis we can determine the serum gluey IV inthe hepatis sufferers.

目的:检测不同肝病患者的血清IV型胶原含量,以判断其在肝硬化诊断中的应用。

56. Objective Understand the relation of hepatocirrhosis sufferer s function of liver and the change of thyroxin s level.

目的了解肝硬化患者肝功能与甲状腺激素水平变化的关系。

57. Objective To search for an operation method which can treat hepatocirrhosis and portal hypertension.

目的探讨一种治疗肝硬化门脉高压症的术式。

58. Objective To investigate the clinical application of color ultrasonography in the patients with portal hypertension due to hepatocirrhosis after partial embolization of splenic artery (PESA).

目的探讨彩色多普勒超声观测肝硬化门静脉高压症患者行部分脾动脉栓塞术的临床应用价值。

59. Objective To study the clinical effects of a traditional Chinese medicine compound,Yingganfukang (GFK),in treating B-type virus hepatitis and hepatocirrhosis.

目的研究硬肝复康临床治疗肝炎和肝硬化的效果。方法将四川省部分市、地、县及军队医院临床应用硬肝复康的资料进行小结和分析。

60. Objective To explore the changes of blood cytology index of hepatocirrhosis in patients.

目的研究肝硬化患者血液细胞学指标的变化规律。

61. Objective To observe the efficacy of Octriotid in the treatment of ruptured hemorrhage of esophageal piles from hepatocirrhosis.

目的观察奥曲肽治疗肝硬变食管静脉曲张破裂出血的临床疗效。

62. Objective To observe the effect and machanism of Xiaogu Granule (Granules for treating tympanites) plus ultrafiltration and reinfusion of ascites on refractory ascites resulted from hepatocirrhosis.

目的观察消臌颗粒配合腹水超滤浓缩回输治疗顽固性肝硬化腹水的临床疗效并探讨其作用机制。

63. Objective：To study the change of red immune function in patients with hepatocirrhosis.

目的：探讨肝硬化患者红细胞免疫功能的变化。

64. Keywords Spirulina platensis;selenium;hepatocirrhosis;selenoenzyme;proliferation;

硒;螺旋藻;肝纤维化;硒酶;细胞增殖;

65. Tiopronin is a novel sulfhydryl glycin derivative,which has been used clinically for the treatment of all kinds of hepatitis,fatty liver,hepatocirrhosis.

硫普罗宁是一种新型的含巯基的甘氨酸衍生物,临床上用于各种肝炎、脂肪肝和肝硬化的治疗等。

66. Its functions include: remedy the negative nitrogen balance after operation and remedy the hypoproteinemia caused by severe infection or hepatocirrhosis, etc.

纠正手术等创伤后的负氮平衡状态，纠正重度感染及肝硬化等所致的低蛋白血症；

67. Age ranged from 17 to 78 years.The hemorrhagic causes included:hypertension in 5cases,hepatocirrhosis and portal hypertension in 2 cases,and unknown reason in 1case.

结果8例中发生于高血压5例，肝硬化、门脉高压症2例，原因不明1例。

68. RESULTS: Baogan pills could improve liver function and inhibit replication of hepatitis virus, especially could improve the early parameters of hepatocirrhosis.

结果:保肝丸有改善肝功能和抑制病毒复制的作用,尤其对肝硬化的早期指标有改善作用。

69. Results The level of TF3,TF4 and TSH in chronic hepatitis,hepatocirrhosis compensated and hepatocirrhosis decompensated were analogous,lower than those in normal group(P<0.001,P<0.005,P<0.005).

结果慢性肝炎、肝硬化代偿期与失代偿期的TF3、TF4及促甲状腺激素(TSH)表现基本一致,分别较正常组有明显下降(P<0.001,P<0.005,P<0.005),且与肝脏损害程度成正比;

70. Results The incidence of SBP in patients with Hepatocirrhosis was 39.6%.The Gram negative bacilli were bacteria.

结果肝硬化合并SBP的发生率为39.6%，致病菌为革兰阴性(G(上标-))菌。

71. Results 25 of all cases (89.3%) were cured.3 cases died because of bile-vessel fistulas and advanced hepatocirrhosis.

结果：全组治愈25例(89.3%)另3例因胆管血管瘘和晚期肝硬化死亡。

72. Keywords colon perfusion dialysis therapy;hepatocirrhosis;ascites;endotoxemia;

结肠灌注透析;肝硬化;腹水;内毒素血症;

73. Conclusion CT scan imaging can clearly display the abnormal extrastomach ligment in acute necropancreatitis,hepatocirrhosis with portal hypertension,metastases and lymphomas.

结论CT扫描能清楚地显示急性坏死性胰腺炎、肝硬化门静脉高压、转移瘤及恶性淋巴瘤所致的胃周韧带改变。

74. Conclusion The results indicated that it is an ideal operation method in the treatment of hepatocirrhosis and portal hypertension.

结论结果提示经腹脾大部分切除大网膜肺固定术是治疗肝硬化门脉高压症的一种理想术式。

75. Conclusion The numbers of erythrocyte、leukocyte and thrombocyte decreased in hepatocirrhosis patients.

结论肝硬化患者白细胞、红细胞、血小板3系均减低。

76. Conclusion: UBIO could promote the recover and improvement of liver function on liver trauma after operation for symptom of hepatocirrhosis portal hypertension.

结论：UBIO治疗能促进肝硬化门脉高压症术后肝损伤患者的肝功能恢复。

77. Keywords aged;hepatocirrhosis;nosocomial infection;risk factors;splenomegaly;

老年人;肝硬化;医院感染;危险因素;脾大;

78. Keywords Hepatitis;Hepatocirrhosis;Liver cancer;Prealbumin;

肝炎;肝硬化;肝癌;前白蛋白;

79. The HBeAg positive rate in hepatocirrhosis(16/49) and PHC(10/50) was lower than in CHB(30/51)(P<0.05,P<0.01).

肝炎后肝硬化的HBeAg阳性率(16/49)与原发性肝癌组的(10/50)均低于慢性乙型肝炎组(30/51)(P<0.05,P<0.01);

80. Multi-analysis: Characteristics of Traditional Chinese Medical Syndrome of Hepatocirrhosis

肝炎肝硬化中医证候特点的多元分析